[go: up one dir, main page]

AU2002305682A1 - Delivery of diphenhydramine through an inhalation route - Google Patents

Delivery of diphenhydramine through an inhalation route

Info

Publication number
AU2002305682A1
AU2002305682A1 AU2002305682A AU2002305682A AU2002305682A1 AU 2002305682 A1 AU2002305682 A1 AU 2002305682A1 AU 2002305682 A AU2002305682 A AU 2002305682A AU 2002305682 A AU2002305682 A AU 2002305682A AU 2002305682 A1 AU2002305682 A1 AU 2002305682A1
Authority
AU
Australia
Prior art keywords
diphenhydramine
delivery
inhalation route
inhalation
route
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002305682A
Inventor
Joshua D. Rabinowitz
Alejandro C. Zaffaroni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexza Pharmaceuticals Inc
Original Assignee
Alexza Molecular Delivery Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexza Molecular Delivery Corp filed Critical Alexza Molecular Delivery Corp
Publication of AU2002305682A1 publication Critical patent/AU2002305682A1/en
Abandoned legal-status Critical Current

Links

AU2002305682A 2001-05-24 2002-05-21 Delivery of diphenhydramine through an inhalation route Abandoned AU2002305682A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/294,203 2001-05-24
US60/317,479 2001-09-05

Publications (1)

Publication Number Publication Date
AU2002305682A1 true AU2002305682A1 (en) 2002-12-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002363947A1 (en) Delivery of caffeine through an inhalation route
AU2002340083A1 (en) Nasal nebulizer
AU2003239433A1 (en) Delivery of drug amines through an inhalation route
WO2002089880A8 (en) Inhalers
AU2001248673A1 (en) Nasal inhaler
AU2002342073A1 (en) Benefit agent delivery systems
GB0128220D0 (en) Location based delivery of service data
AU2002246378A1 (en) Respirator
EP1438086A4 (en) Nasal cannula
AU2002339370A1 (en) Nasal Spray
AU2002348971A1 (en) Ph-sensitive liposomes for targeted drug delivery
AU2002354927A1 (en) Vapor delivery system
AU2002240942A1 (en) Improved delivery of benefit agents
AU2002305682A1 (en) Delivery of diphenhydramine through an inhalation route
GB0130307D0 (en) Air delivery system
AU2002259259A1 (en) Delivery of antidepressants through an inhalation route
AU2002309948A1 (en) Delivery of diazepam through an inhalation route
AU2002259225A1 (en) Delivery of muscle relaxants through an inhalation route
AU2002339308A1 (en) Delivery of antiemetics through an inhalation route
AU2002310016A1 (en) Delivery of beta-blockers through an inhalation route
AU2002312038A1 (en) Delivery of benzodiazepines through an inhalation route
AU2002259254A1 (en) Delivery of analgesics through an inhalation route
AU2002311980A1 (en) Delivery of anti-migraine compounds through an inhalation route
AU2002310073A1 (en) Delivery of physiologically active compounds through an inhalation route
AU2002303834A1 (en) Delivery of compounds for the treatment of parkinsons through an inhalation route